Ameriprise’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.5M Sell
284,459
-70,337
-20% -$2.94M ﹤0.01% 1966
2025
Q4
$16.1M Buy
354,796
+154,846
+77% +$5.67M ﹤0.01% 1576
2025
Q3
$6.09M Buy
199,950
+14,677
+8% +$451K ﹤0.01% 2287
2025
Q2
$5.45M Buy
185,273
+84,469
+84% +$2.53M ﹤0.01% 2291
2025
Q1
$3.52M Sell
100,804
-6,152
-6% -$244K ﹤0.01% 2559
2024
Q4
$4.76M Sell
106,956
-9,662
-8% -$434K ﹤0.01% 2388
2024
Q3
$5.08M Sell
116,618
-12,473
-10% -$470K ﹤0.01% 2365
2024
Q2
$3.49M Sell
129,091
-4,592
-3% -$133K ﹤0.01% 2558
2024
Q1
$3.91M Sell
133,683
-2,389
-2% -$72.4K ﹤0.01% 2515
2023
Q4
$5.12M Sell
136,072
-86,052
-39% -$3.16M ﹤0.01% 2333
2023
Q3
$10M Buy
222,124
+32,148
+17% +$1.95M ﹤0.01% 1704
2023
Q2
$14M Sell
189,976
-18,371
-9% -$1.24M ﹤0.01% 1500
2023
Q1
$12.2M Sell
208,347
-283,485
-58% -$15.6M ﹤0.01% 1607
2022
Q4
$24.8M Sell
491,832
-72,789
-13% -$4.37M 0.01% 1094
2022
Q3
$49.1M Buy
564,621
+229,639
+69% +$24.1M 0.02% 707
2022
Q2
$38.1M Buy
334,982
+8,392
+3% +$963K 0.01% 838
2022
Q1
$42.3M Buy
326,590
+10,163
+3% +$1.46M 0.01% 881
2021
Q4
$57.1M Buy
316,427
+229
+0.1% +$39.7K 0.02% 781
2021
Q3
$46.9M Sell
316,198
-8,636
-3% -$1.32M 0.02% 796
2021
Q2
$49.2M Sell
324,834
-16,180
-5% -$2.25M 0.02% 811
2021
Q1
$44.3M Sell
341,014
-6,310
-2% -$809K 0.01% 823
2020
Q4
$41.7M Sell
347,324
-12,158
-3% -$1.19M 0.01% 826
2020
Q3
$26.8M Sell
359,482
-47,033
-12% -$3.26M 0.01% 921
2020
Q2
$28.7M Sell
406,515
-76,313
-16% -$5.22M 0.01% 870
2020
Q1
$31.7M Buy
482,828
+1,629
+0.3% +$130K 0.02% 717
2019
Q4
$39.3M Buy
481,199
+16,623
+4% +$1.28M 0.02% 806
2019
Q3
$33.6M Buy
464,576
+11,869
+3% +$871K 0.02% 837
2019
Q2
$38.9M Buy
452,707
+48,317
+12% +$3.93M 0.02% 796
2019
Q1
$32.7M Sell
404,390
-16,355
-4% -$1.22M 0.02% 859
2018
Q4
$25.8M Sell
420,745
-81,207
-16% -$5.5M 0.01% 916
2018
Q3
$36.1M Buy
501,952
+57,054
+13% +$3.59M 0.01% 919
2018
Q2
$23.3M Buy
444,898
+15,941
+4% +$750K 0.01% 1067
2018
Q1
$18.6M Sell
428,957
-17,996
-4% -$827K 0.01% 1177
2017
Q4
$21.7M Buy
446,953
+67,589
+18% +$3.41M 0.01% 1014
2017
Q3
$19.4M Buy
379,364
+25,447
+7% +$1.22M 0.01% 1058
2017
Q2
$15.3M Buy
353,917
+1,386
+0.4% +$57.6K 0.01% 1226
2017
Q1
$14.3M Buy
352,531
+3,698
+1% +$136K 0.01% 1249
2016
Q4
$11.8M Sell
348,833
-28,215
-7% -$971K 0.01% 1399
2016
Q3
$14.4M Sell
377,048
-80,760
-18% -$3.01M 0.01% 1153
2016
Q2
$15.7M Sell
457,808
-21,475
-4% -$670K 0.01% 1060
2016
Q1
$13.4M Sell
479,283
-22,017
-4% -$605K 0.01% 1198
2015
Q4
$15.6M Buy
501,300
+35,238
+8% +$1.04M 0.01% 1107
2015
Q3
$14.5M Buy
466,062
+54,532
+13% +$1.95M 0.01% 1163
2015
Q2
$15.5M Buy
411,530
+80,628
+24% +$2.94M 0.01% 1204
2015
Q1
$11.6M Sell
330,902
-26,296
-7% -$867K 0.01% 1436
2014
Q4
$11.8M Buy
357,198
+35,634
+11% +$1.1M 0.01% 1370
2014
Q3
$8.79M Buy
321,564
+4,215
+1% +$115K 0.01% 1584
2014
Q2
$9.11M Buy
317,349
+9,989
+3% +$270K 0.01% 1619
2014
Q1
$8.8M Buy
307,360
+110
+0% +$3.01K 0.01% 1625
2013
Q4
$7.84M Sell
307,250
-15,132
-5% -$361K ﹤0.01% 1678
2013
Q3
$7.63M Buy
322,382
+84,884
+36% +$1.89M 0.01% 1648
2013
Q2
$4.88M Buy
+237,498
New +$4.39M ﹤0.01% 1897

Other funds holding OMCL

Ameriprise's OMCL Position: Q1 2026 in Review

Ameriprise reduced its Omnicell (OMCL) stake by 20% in Q1 2026, selling an estimated $2.94M and leaving 284,459 shares worth $9.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

Ameriprise first reported a position in OMCL in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Ameriprise held 284,459 shares of Omnicell worth $9.5M as of Q1 2026.
  • Ameriprise sold 70,337 Omnicell shares in Q1 2026, an estimated $2.94M.
  • Omnicell made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1966 holding.
  • Ameriprise first reported a position in Omnicell in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Omnicell position peaked at $57.1M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.